Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
Aclaris Therapeutics和其他3支低于2美元的股票正在被内部人士购买
The Dow Jones index closed higher by more than 100 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道琼斯指数周一收涨逾100点。当内部人士购买或出售股票时,表明他们对公司前景的信心或担忧。对于对便宜股票感兴趣的投资者和交易者来说,他们可以将此视为整体投资或交易决策中的因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是几个近期关于低价股的值得关注的内部交易。了解更多,请查看Benzinga内幕交易平台。
BranchOut Food
BranchOut Food
- The Trade: BranchOut Food Inc. (NASDAQ:BOF) Director Byron Riche Jones bought a total of 41,755 shares at an average price of $0.99. To acquire these shares, it cost around $41,337.
- What's Happening: On June 26, Branchout Food announced the pricing of its $1.4 million underwritten public offering of 1.75 million shares of common stock at $0.80 per share.
- What BranchOut Food Does: Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders.
- 交易:BranchOut Food Inc.(纳斯达克:BOF)董事Byron Riche Jones以平均价0.99美元购买了总共41755股股票。要获得这些股票,需要花费约41337美元。
- 最新动态:6月26日,Branchout Food宣布其1.4百万美元的注册公开发行175万股普通股,价格为每股0.8美元。
- Branchout Food Inc从事植物基础的脱水水果和蔬菜零食和粉末的开发,销售和分销。
Innovative Food Holdings
Innovative Food Holdings
- The Trade: Innovative Food Holdings, Inc. (OTC:IVFH) Director Denver Johnson Smith acquired a total of 350,000 shares at an average price of $1.20. To acquire these shares, it cost around $420,000.
- What's Happening: On May 14, the company said revenues in the first quarter fell 5.7% to $15.7 million.
- What Innovative Food Holdings Does: Innovative Food Holdings Inc through its subsidiaries is engaged in the distribution of perishables and specialty food products.
- 交易:Innovative Food Holdings,Inc.(场外交易:IVFH)董事Denver Johnson Smith以平均价格1.20美元收购了共350,000股股票。要获得这些股票,需要付出约42万美元。
- 最新动态:5月14日,该公司表示第一季度营收下降了5.7%,至1570万美元。
- Innovative Food Holdings Inc通过其子公司从事易腐食品和特殊食品产品的分销。
Crown Equity Holdings
Crown Equity Holdings
- The Trade: Crown Equity Holdings Inc. (OTC:CRWE) Marketing/Merger/Acq. Officer Jamie Hadfield acquired a total of 5,000 shares at an average price of $0.25. The insider spent around $1,250 to buy those shares.
- What's Happening: On June 14, Crown Equity named Ahmad Moradi as the new Chairman of the Board and Chief Strategic & Science Officer.
- What Crown Equity Holdings Does: Crown Equity Holdings Inc offers services to companies seeking to become public entities in the United States.
- 交易:Crown Equity Holdings Inc.(场外交易:CRWE)市场/并购/收购官员Jamie Hadfield以平均价格0.25美元购买了共5000股股票。这位内部人士花了约1250美元购买这些股票。
- 最新动态:6月14日,Crown Equity任命Ahmad Moradi为新任董事会主席兼首席战略与科学官。
- Crown Equity Holdings Inc为希望成为美国公开公司的公司提供服务。
Aclaris Therapeutics
aclaris therapeutics
- The Trade: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) 10% owner Braden Michael Leonard acquired a total of 154,722 shares at an average price of $1.31. The insider spent around $201,808 to buy those shares.
- What's Happening: On July 16, Aclaris Therapeutics announced the sale of OLUMIANT royalties and milestones to OMERS Life Sciences for up to $31.5 million.
- What Aclaris Therapeutics Does: Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States.
- 交易:Aclaris Therapeutics,Inc.(纳斯达克:ACRS)10%所有者Braden Michael Leonard以平均价1.31美元购买了共154,722股股票。这位内部人士花了约20.18万美元购买这些股票。
- 最新动态:7月16日,Aclaris Therapeutics宣布将OLUMIANT的版税和里程碑转让给OMERS生命科学,最高可达3150万美元。
- aclaris therapeutics inc是一家在美国运营的临床阶段生物制药公司。
Read More:
阅读更多:
- Wall Street's Most Accurate Analysts Say Hold These 3 Utilities Stocks With Over 5% Dividend Yields
- 华尔街最准确的分析师表示,建议持有这3只能源股票,其股息收益率超过5%。